Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-061424
Filing Date
2025-03-24
Accepted
2025-03-24 17:00:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d899816ddefa14a.htm DEFA14A 11397
2 GRAPHIC g899816g02a01.jpg GRAPHIC 420670
3 GRAPHIC g899816g02a02.jpg GRAPHIC 335503
  Complete submission text file 0001193125-25-061424.txt   1054123
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36407 | Film No.: 25764934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)